title: Add-ons in IVF programme - Hype or Hope?
abstract: A series of new technologies and adjuvant therapies have been advocated in order to improve the success of IVF treatment. Dehydro-epiandrostenedione, growth hormones, Coenzyme Q 10, calcium ionosphores, immune therapy, heparin, low-dose aspirin, and vasodilators are among commonly prescribed pharmacological adjuvants. New technologies that are proposed to improve IVF outcomes include advanced sperm selection procedures, time- lapse embryo monitoring, preimplantation genetic screening, assisted hatching endometrial injury or embryo-glue. This review looked into current evidence to justify the use of these co-interventions and whether some of them can still be offered while awaiting more robust evidence to con rm or refute their role.
authors.affiliation: CREATE Fertility, 150 Cheapside, St Pauls, London EC2V 6ET, United Kingdom.
authors.forename: A K
authors.initials: AK
authors.lastname: Datta
authors.affiliation: CREATE Fertility, 150 Cheapside, St Pauls, London EC2V 6ET, United Kingdom.
authors.forename: S
authors.initials: S
authors.lastname: Campbell
authors.affiliation: CREATE Fertility, 150 Cheapside, St Pauls, London EC2V 6ET, United Kingdom.
authors.forename: B
authors.initials: B
authors.lastname: Deval
authors.affiliation: CREATE Fertility, 150 Cheapside, St Pauls, London EC2V 6ET, United Kingdom.
authors.forename: G
authors.initials: G
authors.lastname: Nargund
keywords: Adjuvants; IVF; assisted conception; assisted reproduction; malpractice; over-treatment; technology